Dental Surgery without Clotting Factor Replacement Therapy during Continued Prophylaxis with Marstacimab, an Inhibitory TFPI Monoclonal Antibody.

Bokemeyer NK, Rolling CC, Freytag M, Langer F

Open source

DOI
10.1055/a-2854-6184
Published
2026 May 21
Container
Hamostaseologie
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1055/a-2854-6184,
  title = {Dental Surgery without Clotting Factor Replacement Therapy during Continued Prophylaxis with Marstacimab, an Inhibitory TFPI Monoclonal Antibody.},
  author = {Bokemeyer NK and Rolling CC and Freytag M and Langer F},
  year = {2026},
  journal = {Hamostaseologie},
  doi = {10.1055/a-2854-6184},
  url = {https://doi.org/10.1055/a-2854-6184}
}

RIS

TY  - JOUR
TI  - Dental Surgery without Clotting Factor Replacement Therapy during Continued Prophylaxis with Marstacimab, an Inhibitory TFPI Monoclonal Antibody.
AU  - Bokemeyer NK
AU  - Rolling CC
AU  - Freytag M
AU  - Langer F
PY  - 2026
JO  - Hamostaseologie
DO  - 10.1055/a-2854-6184
UR  - https://doi.org/10.1055/a-2854-6184
ER  - 

APA

NK, B., CC, R., M, F., & F, L. (2026). Dental Surgery without Clotting Factor Replacement Therapy during Continued Prophylaxis with Marstacimab, an Inhibitory TFPI Monoclonal Antibody.. Hamostaseologie. https://doi.org/10.1055/a-2854-6184

Source records